MedPath

Effect of Carbonated Soft Drinks on the Body Weight

Not Applicable
Completed
Conditions
Obesity
Metabolic; Complications
Dietary Habits
Interventions
Other: Semi-skimmed milk
Other: Aspartame-sweetened soft drink
Other: Water
Other: Sugar-sweetened soft drink
Registration Number
NCT00777647
Lead Sponsor
Aarhus University Hospital
Brief Summary

Compared to solid foods, the nutritional energy of drinks may bypass the appetite regulation leading to obesity development. Although drinks sweetened with aspartame are available the anticipated positive effect of these drinks on obesity development has not been convincing. However, the mechanisms linking drinks intake to obesity are yet to be clarified.

The investigators aim is to investigate the long-term effects of intake of soft drinks, milk and water. The study is a parallel, intervention trial with 80 overweight, healthy volunteers. They will be randomly selected to drink one liter a day of one of the four drinks for six months. The objectives are changes in numerous circulating metabolic risk factors, changes in body weight, anthropometric data and fat distribution (measured by DEXA, MRI and MR-spectroscopy).

The investigators expect to clarify the mechanisms linking drinking habits to obesity development and provide scientifically based nutritional guidelines.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age between 20-50 years;
  • BMI between 28-36 kg/m2;
  • Weight stabile 3 months prior to the study inclusion;
  • Less than 10 hours of weekly exercise
Exclusion Criteria
  • Diabetes
  • Allergic to phenylalanine or milk
  • Smoking
  • Pregnancy or breast-feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Semi-skimmed milkSemi-skimmed milk202kJ/100mL
Aspartame-sweetened soft drinkAspartame-sweetened soft drink1.5kJ/100mL
WaterWater0kJ/100mL
Sugar-sweetened soft drinkSugar-sweetened soft drink54g sugar/L, 180kJ/100mL
Primary Outcome Measures
NameTimeMethod
Body Weight (kg)Six months
MR spectroscopySix months

to assess liver fat and skeletal muscle fat

Dual-energy X-ray absorptiometry (DEXA) scanSix months

to assess total fat mass (kg), lean body mass (kg), and bone mass (kg)

Magnetic resonance imagingSix months

to assess visceral adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAAT)

Secondary Outcome Measures
NameTimeMethod
Fasting plasma PAI-1Six months

ng/ml

fasting serum insulinSix months

pmol/L

Blood pressureSix months

Systolic and diastolic blood pressure (mmHg)

Circulating metabolic parameters: including serum urateSix months

mmol/L

Oral Glucose Tolerance Test (OGTT)Six months

AUC OGTT glucose and insulin, AUC HOMA-IR, and Matzuda index

Fasting plasma FFASix months

mmol/L

fasting plasma glucoseSix months

mmol/L

Fasting blood lipidsSix months

Total, LDL, and HDL cholesterol, and TAG (mmol/L)

Trial Locations

Locations (1)

Department of Internal Medicine/Endocrinology C, Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath